Floatz logo

185 assets in Pancreatic Adenocarcinoma

Therapeutic assets addressing Pancreatic Adenocarcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Dual-Function Antibody Pd-1/Ctla-4
Pancreatic Adenocarcinoma
Ruijin HospitalP2CCC (53)
dz-002
Pancreatic Adenocarcinoma
Hoag Memorial Hospital PresbyterianP2CCC (53)
Enfortumab Vedotin (Fully Human Monoclonal Antibody Conjugated To A Cytotoxic Agent Monomethyl Auristatin E (Mmae) Targeting Nectin-4)
Pancreatic Adenocarcinoma
University of Kansas Medical CenterP2CCC (53)
Fapi-46
Pancreatic Adenocarcinoma
University Hospital, BordeauxP2CCC (53)
Fludarabine
Pancreatic Adenocarcinoma
University of PennsylvaniaP1/2CCC (53)
Hrs-4642
Pancreatic Adenocarcinoma
Zhejiang UniversityP2CCC (53)
Human Adenovirus C Serotype 5
Pancreatic Adenocarcinoma
Thomas Jefferson UniversityP2CCC (53)
ibi343
Pancreatic Adenocarcinoma
Zhejiang UniversityP2CCC (53)
Immunoglobulin G1, Anti-(Humanized Mouse Monoclonal Hr3 .Beta.1 Chain Anti-Human Epidermal Growth Factor Receptor), Disulfide With Humanized Mouse Monoclonal Hr3 .Kappa.-Chain, Dimer
Pancreatic Adenocarcinoma
Zhejiang UniversityP2CCC (53)
Immunoglobulin G4, Anti-(Human Programmed Cell Death Protein 1) (Human Monoclonal Regn2810 Heavy Chain), Disulfide With Human Monoclonal Regn2810 .Kappa.-Chain, Dimer
Pancreatic Adenocarcinoma
Gulam ManjiP2CCC (53)
Penpulimab
Pancreatic Adenocarcinoma
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolP2CCC (53)
Polo-Like Kinase 1 Inhibitor Nms-1286937
Pancreatic Adenocarcinoma
OHSU Knight Cancer InstituteP2CCC (53)
Sapropterin Dihydrochloride
Pancreatic Adenocarcinoma
Sun Yat-sen UniversityP2CCC (53)
Simvastatin
Pancreatic Adenocarcinoma
National Cancer Institute, NaplesP2CCC (53)
Surufatinib
Pancreatic Adenocarcinoma
Sun Yat-sen UniversityP2CCC (53)
Toripalimab
Pancreatic Adenocarcinoma
Sun Yat-sen UniversityP2CCC (53)
Verteporfin
Pancreatic Adenocarcinoma
Mayo ClinicP2CCC (53)
Zentalis
Pancreatic Adenocarcinoma
Brandon Huffman, MDP2CCC (53)
Cobimetinib
Pancreatic Adenocarcinoma
OHSU Knight Cancer InstituteP1/2CCC (52)
Valproic Acid
Pancreatic Adenocarcinoma
National Cancer Institute, NaplesP2CCC (52)
2-CHLORO-N6-(3-IODOBENZYL)ADENOSINE-5'-N-METHYLURONAMIDE
Pancreatic Adenocarcinoma
Can-Fite BioPharmaP2CCC (51)
Avutometinib
Pancreatic Adenocarcinoma
Washington University School of MedicineP2CCC (51)
Dostarlimab
Pancreatic Adenocarcinoma
UNICANCERP2CCC (51)
esk981
Pancreatic Adenocarcinoma
University of Michigan Rogel Cancer CenterP2CCC (51)
Floxuridine
Pancreatic Adenocarcinoma
Corewell Health WestP2CCC (51)
Lomustine
Pancreatic Adenocarcinoma
Actuate Therapeutics Inc.P2CCC (51)
Tocilizumab
Pancreatic Adenocarcinoma
University of PennsylvaniaP1/2CCC (51)
Zoledronate
Pancreatic Adenocarcinoma
University of NebraskaP2CCC (51)
Imm-6-415
Pancreatic Adenocarcinoma
Immuneering CorporationP1/2CCC (50)
y101d
Pancreatic Adenocarcinoma
Wuhan YZY Biopharma Co., Ltd.P1/2CCC (50)
Dabrafenib
Pancreatic Adenocarcinoma
Immuneering CorporationP1/2CCC (49)
Elraglusib
Pancreatic Adenocarcinoma
Colin D. Weekes, M.D., PhDP2CCC (49)
Domvanalimab
Pancreatic Adenocarcinoma
James Cleary, MD, PhDP1/2CCC (48)
Inv-8989
Pancreatic Adenocarcinoma
Shenzhen Ionova Life Sciences Co., Ltd.P1/2CCC (48)
jdb153
Pancreatic Adenocarcinoma
West China HospitalP1/2CCC (48)
Serplulimab
Pancreatic Adenocarcinoma
West China HospitalP1/2CCC (48)
Aguix
Pancreatic Adenocarcinoma
Dana-Farber Cancer InstituteP1/2CC (47)
Fluoromisonidazole
Pancreatic Adenocarcinoma
National Cancer Institute (NCI)P2CC (47)
[68ga]ga-oncofap administration
Pancreatic Adenocarcinoma
Philogen S.p.A.P1CC (46)
Cb Car-Nk18.2
Pancreatic Adenocarcinoma
Zhejiang Provincial People's HospitalP1CC (46)
ctx131
Pancreatic Adenocarcinoma
CRISPR Therapeutics AGP1/2CC (46)
Certepetide
Pancreatic Adenocarcinoma
Lisata Therapeutics, Inc.P1/2CC (45)
Individualized Anti-Tumor New Antigen Ineo-Vac-R01
Pancreatic Adenocarcinoma
Zhejiang UniversityP1/2CC (45)
Mesenchymal Stem Cells Derived Exosomes
Pancreatic Adenocarcinoma
M.D. Anderson Cancer CenterP1/2CC (45)
Pertzye
Pancreatic Adenocarcinoma
Memorial Sloan Kettering Cancer CenterP1/2CC (45)
rr001
Pancreatic Adenocarcinoma
EIR Biotherapies s.r.l.P1/2CC (45)
Samuraciclib
Pancreatic Adenocarcinoma
University Health Network, TorontoP1/2CC (45)
Sotigalimab
Pancreatic Adenocarcinoma
James Cleary, MD, PhDP1/2CC (45)
Tipiracil
Pancreatic Adenocarcinoma
Emory UniversityP1/2CC (45)
Trifluridine
Pancreatic Adenocarcinoma
Emory UniversityP1/2CC (45)
Showing 51 to 100 of 185 assets
PreviousPage 2 of 4Next